Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando D'Amico

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
United European Gastroenterology Journal|January 22, 2022
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?Ferdinando D'Amico, Alessandra Zilli, Gionata Fiorino
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
"Unraveling the mysteries of IBD: Innovations and insights into the management of Crohn's disease and ulcerative colitis"Ferdinando D'Amico, Sarah Bencardino, Silvio Danese
Expert Review of Clinical Immunology|July 28, 2022
Could small molecules be used in combination with biologics for inflammatory bowel disease?Ferdinando D'Amico, Silvio Danese, Gionata Fiorino
Gastroenterology|December 13, 2021
Positioning Ozanimod in Ulcerative Colitis: Restoring Leukocyte Traffic Under ControlFerdinando D'Amico, Mariangela Allocca, Gionata Fiorino
Expert Opinion on Emerging Drugs|March 6, 2023
Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trialsLaura Neurath, Ferdinando D'Amico, Silvio Danese
The New England Journal of Medicine|May 4, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Gastroenterology|May 4, 2020
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis OrganizationFerdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take StockFerdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|October 5, 2023
Disease Clearance is not Synonymous with CureFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Expert Opinion on Biological Therapy|January 18, 2020
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?Ferdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
United European Gastroenterology Journal|January 22, 2022
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?Ferdinando D'Amico, Alessandra Zilli, Gionata Fiorino
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
"Unraveling the mysteries of IBD: Innovations and insights into the management of Crohn's disease and ulcerative colitis"Ferdinando D'Amico, Sarah Bencardino, Silvio Danese
Expert Review of Clinical Immunology|July 28, 2022
Could small molecules be used in combination with biologics for inflammatory bowel disease?Ferdinando D'Amico, Silvio Danese, Gionata Fiorino
Gastroenterology|December 13, 2021
Positioning Ozanimod in Ulcerative Colitis: Restoring Leukocyte Traffic Under ControlFerdinando D'Amico, Mariangela Allocca, Gionata Fiorino
Expert Opinion on Emerging Drugs|March 6, 2023
Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trialsLaura Neurath, Ferdinando D'Amico, Silvio Danese
The New England Journal of Medicine|May 4, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Gastroenterology|May 4, 2020
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis OrganizationFerdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take StockFerdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|October 5, 2023
Disease Clearance is not Synonymous with CureFerdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese
Expert Opinion on Biological Therapy|January 18, 2020
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?Ferdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Pageof 22